Concurrent use of comedications reduces adherence to antiretroviral therapy among HIV-infected patients

Journal of Managed Care Pharmacy

Volumn 20, Issue 8, 2014, Pages 844-850

  Cantudo Cuenca, Maria Rosa ^a   Jiménez Galán, Rocio ^a   Almeida González, Carmen V ^b   Morillo Verdugo, Ramón ^a  

^a Pharmacy Department   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PRESCRIPTION DRUG;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CHRONIC DISEASE; COMORBIDITY; DISEASE TRANSMISSION; DRUG USE; EMERGENCY WARD; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL PHARMACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORISKY MEDICATION ADHERENCE SCALE; OUTPATIENT; PATIENT COMPLIANCE; PHARMACEUTICAL CARE; PHARMACIST; POLYPHARMACY; PRESCRIPTION; RATING SCALE; VIRUS LOAD; ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INTRAVENOUS DRUG ABUSE; MEDICATION COMPLIANCE; NONHUMAN; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; THERAPEUTIC INDEX; TREATMENT REFUSAL; CD4+ T LYMPHOCYTE; DRUG EFFECTS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; MIDDLE AGED; PROCEDURES;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; COINFECTION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; POLYPHARMACY; PRESCRIPTION DRUGS; PROSPECTIVE STUDIES; VIRAL LOAD;

EID: 84904898379     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2014.20.8.844     Document Type: Article

References (46)

1. D'Arminio Monforte A, Sabin CA, Phillips A, et al. The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy. Arch Intern Med. 2005;165(4):416-23.
2. Ray M, Logan R, Sterne JA, et al, and the HIV-CAUSAL Collaboration. The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS. 2010;24(1):123-37.
3. Sterne JA, Hernán MA, Ledergerber B, et al. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet. 2005;366(9483):378-84.
4. Hogg R, Lima V, Sterne JA, et al, and the Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372(9635):293-99.
5. Orlando G, Meraviglia P, Cordier L, et al. Antiretroviral treatment and agerelated comorbidities in a cohort of older HIV-infected patients. HIV Med. 2006;7(8):549-57.
6. Stoff DM, Khalsa JH, Monjan A, Portegies P. Introduction: HIV/AIDS and aging. AIDS. 2004;18(Suppl 1):S1-S2.
7. Effros RB, Fletcher CV, Gebo K, et al. Aging and infectious diseases:workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis. 2008;47(4):542-53.
8. Hasse B, Ledergerber B, Furrer H, et al, and the Swiss HIV Cohort Study. Morbidity and aging in HIV-infected persons: the Swiss HIV Cohort Study. Clin Infect Dis. 2011;53(11):1130-39.
9. Marzolini C, Elzi L, Gibbons S, et al, and the Swiss HIV Cohort Study. Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study. Antivir Ther. 2010;15(3):413-23.
10. Edelman EJ, Gordon KS, Glover J, McNicholl IR, Fiellin DA, Justice AC. The next therapeutic challenge in HIV: polypharmacy. Drugs Aging. 2013;30(8):613-28.
11. Morillo Verdugo R, Martín Conde MT, Valverde Merino MP, et al. Development and validation of a prediction model to identify HIV+ patients with drug-related problems: a prediction study [in Spanish]. Farm Hosp. 2012;36(5):343-50.
12. Bretzel R, Boeth J. Polypharmacy and the treatment of HIV/AIDS. J Am Pharm Assoc (Wash). 1996;NS36(12):722a-22e.
13. Martin S, Wolters PL, Calabrese SK, et al. The Antiretroviral Regimen Complexity Index: a novel method of quantifying regimen complexity. J Acquir Immune Defic Syndr. 2007;45(5):535-44.
14. Libby AM, Fish DN, Hosokawa PW, et al. Patient-level medication regimen complexity across populations with chronic disease. Clin Ther. 2013;35(4):385-98.e1.
15. Martin M, Del Cacho E, Codina C, et al. Relationship between adherence level, type of the antiretroviral regimen, and plasma HIV type 1 RNA viral load: a prospective cohort study. AIDS Res Hum Retroviruses. 2008;24(10):1263-68.
16. Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozzette SA. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr. 2000;23(5):386-95.
17. Ammassari A, Trotta MP, Murri R, et al, and the AdlCoNa Study Group. Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr. 2002;31(Suppl 3):S123-S27.
18. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21-30.
19. Ekwunife OI, Oreh C, Ubaka CM. Concurrent use of complementary and alternative medicine with antiretroviral therapy reduces adherence to HIV medications. Int J Pharm Pract. 2012;20(5):340-43.
20. Peltzer K, Preez NF, Ramlagan S, Fomundam H. Use of traditional complementary and alternative medicine for HIV patients in KwaZulu-Natal, South Africa. BMC Public Health. 2008;8:255.
21. Bing EG, Burnam MA, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58(8):721-28.
22. Silverberg MJ, Ray GT, Saunders K, et al. Prescription long-term opioid use in HIV-infected patients. Clin J Pain. 2012;28(1):39-46.
23. Furler MD, Einarson TR, Millson M, Walmsley S, Bendayan R. Medicinal and recreational marijuana use by patients infected with HIV. AIDS Patient Care STDS. 2004;18(4):215-28.
24. Dansak DA. Medical use of recreational drugs by AIDS patients. J Addict Dis. 1997;16(3):25-30.
25. U.S. Department of Health and Human Services. HIV classification:CDC and WHO staging systems. January 2011. Available at: http://hab.hrsa.gov/deliverhivaidscare/clinicalguide11/cg-205_hiv_classification.html. Accessed May 9, 2014.
26. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care.1986;24(1):67-74.
27. Tsai KT, Chen JH, Wen CJ, et al. Medication adherence among geriatric outpatients prescribed multiple medications. Am J Geriatr Pharmacother. 2012;10(1):61-68.
28. Wharshaw G. Introduction: advances and challenges in care of older people with chronic illness. Generations. 2006;30:5-10.
29. Gnjidic D, Hilmer SN, Blyth FM, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify communitydwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65(9):989-95.
30. Consulta de Atención Farmacéutica Patologías Víricas. Complexity index [in Spanish]. Available at: http://indicedecomplejidad.com/complejidad.php. Accessed May 9, 2014.
31. Predictor Index [in Spanish]. Available at: http://estudiopredictor.sefh.es/. Accessed June 5, 2014.
32. Choudhry NK, Fischer MA, Avorn J, et al. The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med. 2011;171(9):814-22.
33. Saini SD, Schoenfeld P, Kaulback K, Dubinsky MC. Effect of medication dosing frequency on adherence in chronic diseases. Am J Manag Care. 2009;15(6):e22-33.
34. Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother. 2011;9(1):11-23.
35. Marcum ZA, Gellad WF. Medication adherence to multidrug regimens. Clin Geriatr Med. 2012;28(2):287-300.
36. Rocha GM, Machado CJ, Acurcio FA, Guimarães MD. Monitoring adherence to antiretroviral treatment in Brazil: an urgent challenge. Cad Saude Publica. 2011;27(Suppl 1):S67-S78.
37. Gutierrez EB, Sartori AM, Schmidt AL, et al. Measuring adherence to antiretroviral treatment: the role of pharmacy records of drug withdrawals. AIDS Behav. 2012;16(6):1482-90.
38. Maiese E, Malmenas M, Atkinson M. Impact of comorbidities on HIV medication persistence: a retrospective database study using US claims data. J Int AIDS Soc. 2012;15(Suppl 4):18063.
39. Nachega JB, Trotta MP, Nelson M, Ammassari A. Impact of metabolic complications on antiretroviral treatment adherence: clinical and public health implications. Curr HIV/AIDS Rep. 2009;6(3):121-29.
40. Moore DJ, Posada C, Parikh M, et al. HIV-infected individuals with co-occurring bipolar disorder evidence poor antiretroviral and psychiatric medication adherence. AIDS Behav. 2012;16(8):2257-66.
41. Gonzalez A, Barinas J, O'Cleirigh C. Substance use: impact on adherence and HIV medical treatment. Curr HIV/AIDS Rep. 2011;8(4):223-34.
42. Braithwaite RS, McGinnis KA, Conigliaro J, et al. A temporal and doseresponse association between alcohol consumption and medication adherence among veterans in care. Alcohol Clin Exp Res. 2005;29(7):1190-97.
43. Buscher A, Hartman C, Kallen MA, Giordano TP. Impact of antiretroviral dosing frequency and pill burden on adherence among newly diagnosed, antiretroviral-naïve HIV patients. Int J STD AIDS. 2012;23(5):351-55.
44. Panel de Expertos de GeSIDA y Plan Nacional Sobre el Sida. Consensus statement by GeSIDA/National AIDS Plan Secretariat on antiretroviral treatment in adults infected by the human immunodeficiency virus [in Spanish]. Enferm Infecc Microbiol Clin. 2013;31(9):602.e1-e98.
45. Cocohoba J, Comfort M, Kianfar H, Johnson MO. A qualitative study examining HIV antiretroviral adherence counseling and support in community pharmacies. J Manag Care Pharm. 2013;19(6):454-60. Available at:http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=16752.
46. Saberi P, Dong BJ, Johnson MO, Greenblatt RM, Cocohoba JM. The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review. Patient Prefer Adherence. 2012;6:297-322.